MedTrace Logo

Glycemic Control in Diabetic Hospitalized Patients

NCT04800861 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-12-27

No results posted yet for this study

Summary

With the advanced management of diabetes and new innovative anti-hyperglycemic therapy hyperglycemia remains a culprit factor affecting the outcome of patients admitted to the hospital in general wards. Efforts from health care providers to assess and control blood sugar by a simplified method such as certified point of care hand-sized glucometers is the fruitful protocol if the results near the target that is endorsed by well-known diabetes societies. In non-critically patients the premeal blood sugar ≤140 mg /dl and ≤ 180 mg /dl after a meal. The unstable economy and political crises with the pandemic of Covid-19 making us use a glucometer to monitor and control the fluctuation of blood sugar in order to decrease the burden on the patients and health care providers in the form of a stay in the hospital and minimize wasting laboratory resources.

Conditions

Sponsors & Collaborators

  • AlFayhaa General Hospital

    lead OTHER

Principal Investigators

  • AbdulSattar J Yousif, MD · Al-Fayhaa teaching hospital

  • Ali Hussein A Alhamza, MD · Al-Fayhaa teaching hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-07-01
Completion
2021-07-01

Countries

  • Iraq

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04800861 on ClinicalTrials.gov